PR Newswire
Aethlon Medical Announces Pricing of a Private Placement and Warrant Inducement, Priced At-The-Market for Aggregate Gross Proceeds of $3.3 Million
📊
AI Sentiment
Positive
7/10
- Home
- AEMD
AEMD
Aethlon Medical Inc.
as of 12-12-2025 4:00pm EST
$3.40
$0.01
-0.29%
Aethlon Medical Inc is a medical therapeutic company. The company is focused on addressing unmet needs in health and biodefense. The company is focused on the development of Hemopurifier, a clinical-stage therapeutic device designed to combat cancer and eliminate life-threatening viruses from the circulatory system.
Chart Type:
Time Range:
| Founded: | 1984 | Country: | United States |
| Employees: | N/A | City: | SAN DIEGO |
| Market Cap: | 3.4M | IPO Year: | N/A |
| Target Price: | $287.50 | AVG Volume (30 days): | 117.4K |
| Analyst Decision: | Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -46.60 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.21 - $84.40 | Next Earning Date: | 11-12-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
AI-Powered AEMD Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated a day ago
AI Recommendation
hold
Model Accuracy: 73.97%
73.97%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Latest Aethlon Medical Inc. News
AEMD Breaking Stock News: Dive into AEMD Ticker-Specific Updates for Smart Investing
Compare AEMD vs Leading Stocks
See how AEMD stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "AEMD Aethlon Medical Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.